Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-COVID-19 vaccine hopes lift world stocks, dollar eases

Mon, 14th Sep 2020 16:59

* AstraZeneca, Pfizer vaccine news lifts equities

* UK, US, Japan central banks meet this week

* Japan's Suga wins ruling party leadership race

* UK parliament to vote on plan to break Brexit divorce
treaty

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

By Herbert Lash

NEW YORK, Sept 14 (Reuters) - The dollar weakened and world
stock markets rose on Monday on encouraging signs of progress in
developing a COVID-19 vaccine, while several multi-billion
dollar deals also help lift the spirit of investors after last
week's downdraft.

Gold edged higher and bond yields were stable as investors
gauge how the U.S. Federal Reserve will put its new approach to
monetary policy into practice and keep its dovish stance at this
week's policy meeting.

Pfizer Inc and BioNTech SE on Saturday
proposed expanding their Phase 3 pivotal COVID-19 vaccine trial
to about 44,000 participants, while increasing the diversity of
the trial population.

Drugmaker AstraZeneca said over the weekend it has
resumed British clinical trials of its COVID-19 vaccine, one of
the most advanced in development, after getting the green light
from safety watchdogs.

"The market reacts positively to any vaccine news," said Tim
Ghriskey, chief investment strategist at Inverness Counsel in
New York. "We're going to see a lot more vaccines come out, and
that is what really is helping the markets."

The World Health Organization reported a record one-day
increase in global coronavirus cases on Sunday, with the total
rising by 307,930 in 24 hours. The biggest increases were from
India, the United States and Brazil.

"There is still some caution in markets because U.S. virus
numbers appear to be picking up again in some states," said
Seema Shah, chief strategist at Principal Global Investors.

"The vaccine news is positive but there is a lot of
skepticism about when they become widely adopted," Shah said.

Plans by Nvidia Corp to buy UK-based chip designer
Arm from Japan's SoftBank Group Corp for as much as $40
billion, a deal expected to reshape the global semiconductor
landscape, also drove sentiment. Nvidia shares
jumped 6.6%.

Oracle surged 5.4% as the cloud services company
said it would team up with China's ByteDance to keep TikTok
operating in the United States, beating Microsoft Corp
in a deal structured as a partnership rather than an outright
sale.

MSCI's benchmark for global equity markets
rose 1.38% to 573.79, while in Europe the broad FTSEurofirst 300
index added 0.07% at 1,429.

On Wall Street, the Dow Jones Industrial Average rose
1.31%, the S&P 500 gained 1.68% and the Nasdaq Composite
added 2.33%.

Overnight in Asia, MSCI's broadest index of Asia-Pacific
shares outside Japan rose 0.9% to its highest in
almost a week. Japan's Nikkei firmed 0.7% after Chief
Cabinet Secretary Yoshihide Suga won a landslide victory in a
ruling party leadership election, paving the way for him to
succeed Prime Minister Shinzo Abe.

The Fed starts a two-day policy meeting on Tuesday, the
first since unveiling a landmark shift to a more tolerant stance
on inflation in August. The Bank of Japan and the Bank of
England announce their respective policy decisions on Thursday.

Sterling, which has been hurt by renewed Brexit turmoil,
firmed before a vote on British Prime Minister Boris Johnson's
plan to break international law by breaching parts of the Brexit
divorce treaty with the European Union.

Sterling was last trading at $1.2873, up 0.63% on the
day, while the dollar index fell 0.294%.

The euro was up 0.23% to $1.1872, and the Japanese
yen strengthened 0.51% versus the greenback at 105.67 per
dollar.

Turkey's lira set a record low against the U.S. dollar
and its dollar bonds came under pressure after Moody's
cut the country's sovereign rating and warned of the risk of a
balance of payment crisis.

Oil prices slipped amid concerns about a stalled global
economic recovery and falling fuel demand as Libya signaled it
would end its months-long blockade and resume output, adding yet
more supply to the market.

Brent crude futures fell $0.22 to $39.61 a barrel.
U.S. crude futures slid $0.11 to $37.22 a barrel.

Spot gold prices rose 0.85% to $1,958.04 an ounce.

(Reporting by Herb Lash; additional reproting by Dhara
Ranasinghe; Editing by Peter Graff, Bernadette Baum and Dan
Grebler)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.